Tolerability of propofol in Wada testing

References

1. ↵
   1. Wada J,
   2. Rasmussen T

   (2007) Intracarotid injection of sodium amytal for the lateralization of cerebral speech dominance 1960. J Neurosurg 106, 1117–1133.
2. ↵
   1. Baxendale S

   (2009) The Wada Test. Curr Opin Neurol 22, 185–189.
3. ↵
   1. Mariappan R,
   2. Manninen P,
   3. McAndrews MP,
   4. Cohn M,
   5. Tai P,
   6. Valiante T,
   7. et al.

   (2013) Intracarotid etomidate is a safe alternative to sodium amobarbital for the Wada Test. J Neurosurg Anesthesiol 25, 408–413.
4. ↵
   1. Patel A,
   2. Wordell C,
   3. Szarlej D

   (2011) Alternatives to sodium amobarbital in the Wada test. Ann Pharmacother 45, 395–401.
5. ↵
   1. Larner AJ,
   2. Mitchell AJ

   (2014) A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia. Int Psychogeriatr 26, 555–563.
6. ↵
   1. Coren S

   (1992) The left-hander syndrome: the causes and consequences of left-handedness (The Free Press, New York (NY)).
7. ↵
   1. Roid GH,
   2. Barram RA

   (2004) Essentials of Stanford-Binet Intelligence Scales (SB5) Assessment (Wiley, Hoboken (NJ)), 1st ed.
8. ↵
   1. Bjelland I,
   2. Dahl AA,
   3. Haug TT,
   4. Neckelmann D

   (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52, 69–77.
9. ↵
   1. Carlson RV,
   2. Boyd KM,
   3. Webb DJ

   (2004) The revision of the Declaration of Helsinki: past, present, and future. Br J Clin Pharmacol 57, 695–713.
10. ↵
    1. Fujii M,
    2. Miyachi S,
    3. Matsubara N,
    4. Kinkori T,
    5. Takebayashi S,
    6. Izumi T,
    7. et al.

    (2011) Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance. World Neurosurg 75, 503–508.
11. ↵
    1. Mikati MA,
    2. Naasan G,
    3. Tarabay H,
    4. El Yamen S,
    5. Baydoun A,
    6. Comair YG

    (2009) Intracarotid propofol testing: a comparative study with amobarbital. Epilepsy Behav 14, 503–507.
12. ↵
    1. Mikuni N,
    2. Takayama M,
    3. Satow T,
    4. Yamada S,
    5. Hayashi N,
    6. Nishida N,
    7. et al.

    (2005) Evaluation of adverse effects in intracarotid propofol injection for WADA test. Neurology 65, 1813–1816.
13. ↵
    1. Takayama M,
    2. Miyamoto S,
    3. Ikeda A,
    4. Mikuni N,
    5. Takahashi JB,
    6. Usui K,
    7. et al.

    (2004) Intracarotid propofol test for speech and memory dominance in man. Neurology 63, 510–515.
14. ↵
    1. Yamaguchi T,
    2. Shojima M,
    3. Delashaw JB Jr.,
    4. Watanabe E

    (2011) Wada test using secobarbital sodium (Ional) to determine language dominance. Br J Neurosurg 25, 203–209.
15. ↵
    1. Loddenkemper T,
    2. Möddel G,
    3. Dinner DS,
    4. Kim H,
    5. Schuele SU,
    6. Alexopoulos AV,
    7. et al.

    (2009) Language assessment in Wada test: comparison of methohexital and amobarbital. Seizure 18, 656–659.
16. ↵
    1. Kim JH,
    2. Joo EY,
    3. Han SJ,
    4. Cho JW,
    5. Lee JH,
    6. Seo DW,
    7. et al.

    (2007) Can pentobarbital replace amobarbital in the Wada test? Epilepsy Behav 11, 378–383.
17. ↵
    1. Kowacs PA,
    2. Mattei TA,
    3. Goulart CR,
    4. da Rocha SF,
    5. Ramina R,
    6. Simão CA,
    7. et al.

    (2011) Seizure-like activity during etomidate-modified Wada test interfere with the evaluation of cognitive functions? Arq Neuropsiquiatr 69, 846–847.
18. ↵
    1. Rang HP,
    2. Dale MM,
    3. Ritter JM,
    4. Flower RJ,
    5. Henderson G

    , eds (2012) General anaesthetic agents. In: Rang and Dale's Pharmacology (Churchill Livingstone Elsevier, London (UK)), 7th ed, 492–502.
19. ↵
    1. Miller RD

    1. Reves JG,
    2. Glass P,
    3. Lubarsky DA,
    4. McEvoy MD,
    5. Martinez-Ruiz R

    (2012) Intravenous Anesthetics. in Miller's Anesthesia, ed Miller RD (Churchill Livingstone Elsevier, Philadelphia (PA)), 7th ed, 719–768.
20. ↵
    1. Bazin JE,
    2. Picard P,
    3. Gabrillargues J,
    4. Dordain M

    (1998) Propofol administered via the carotid artery to achieve a Wada test. Can J Anaesth 45, 707–708.
21. ↵
    1. Silva TM,
    2. Hernández-Fustes OJ,
    3. Bueno ML,
    4. Varela AM,
    5. Machado S

    (2000) The Wada test with propofol in a patient with epilepsy. Arq Neuropsiquiatr 58, 348–350.
22. ↵
    1. Magee JA,
    2. Pender NP,
    3. Abrahams S,
    4. Thornton J,
    5. Delanty N,
    6. Fortune GM

    (2012) A comparison of propofol and amobarbital for use in the Wada test. Seizure 21, 399–401.
23. ↵
    1. Jo YY,
    2. Kwak HJ,
    3. Lee MG,
    4. Lim OK

    (2013) Effect of palonosetron on postanesthetic shivering after propofol-remifentanil total intravenous anesthesia. J Anesth 27, 535–540.
24. ↵
    1. Röhm KD,
    2. Riechmann J,
    3. Boldt J,
    4. Suttner SW,
    5. Piper SN

    (2006) Total intravenous anesthesia with propofol and remifentanil is associated with a nearly twofold higher incidence in postanesthetic shivering than desflurane-fentanyl anesthesia. Med Sci Monit 12, CR452–CR456.
25. ↵
    1. Coon AL,
    2. Colby GP,
    3. Mack WJ,
    4. Feng L,
    5. Meyers P,
    6. Sander Connolly E Jr.

    (2004) Treatment of mechanically-induced vasospasm of the carotid artery in a primate using intra-arterial verapamil: a technical case report. BMC Cardiovasc Disord 4, 11.
26. ↵
    1. Vijayvergiya R,
    2. Otaal PS,
    3. Bagga S,
    4. Modi M

    (2010) Symptomatic carotid vasospasm caused by a distal-protection device during stent angioplasty of the right internal carotid artery. Tex Heart Inst J 37, 226–229.
27. ↵
    1. Bonnet U

    (2011) [Assessment of the addictive risk of propofol]. Fortschr Neurol Psychiatr 79, 442–452.
28. ↵
    1. Koopmann A,
    2. von der Goltz C,
    3. Hermann D,
    4. Kiefer F

    (2011) Propofol addiction initiated by anesthetic use. Am J Psychiatry 168, 211–212.
29. ↵
    1. Möddel G,
    2. Lineweaver T,
    3. Schuele SU,
    4. Reinholz J,
    5. Loddenkemper T

    (2009) Atypical language lateralization in epilepsy patients. Epilepsia 50, 1505–1516.
30. ↵
    1. Van den Heuvel I,
    2. Wurmb TE,
    3. Böttiger BW,
    4. Bernhard M

    (2013) Pros and cons of etomidate - more discussion than evidence? Curr Opin Anaesthesiol 26, 404–408.
31. ↵
    1. Hartle AJ,
    2. Peel PH

    (2012) Etomidate puts patients at risk of adrenal crisis. BMJ 345, e7444.